HPV persistence in treated cervical cancer patients
Part of Cancer, Infections, Women’s health & pregnancy clinical trials.
This study follows patients with cervical cancer caused by HPV (a common virus) who receive radiation and chemotherapy together. Researchers will track whether the HPV virus stays in the body after treatment and how this affects long-term outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with cervical cancer caused by HPV (squamous cell, adenocarcinoma, or adenosquamous types)
- Cancer is at stage IB3, II, III, or IVA (medium to advanced, but not the most advanced stage IVB)
- Never received prior cancer treatment
- Plan to receive radiation therapy combined with chemotherapy as the main treatment
- Not pregnant or in the first few weeks after childbirth
- No serious immune system problems (such as untreated HIV, autoimmune disease, or organ transplant)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks if HPV is still present after standard radiation and chemo for cervical cancer. It may help see how well the treatment worked.
This Phase 3 study tests whether giving additional (adjuvant) chemotherapy after standard chemoradiation can help people whose blood test still shows cancer-related HPV DNA. It may help by lowering the risk of the cervical cancer coming back in people who have a positive blood biomarker after treatment.
This study looks at whether monitoring HPV DNA in your blood after surgery can help predict if cervical cancer comes back, and whether this information can guide decisions about extra treatment. If you join, you'll provide blood samples before and after surgery to track your HPV levels.
This trial checks how well cervical cancer responds to surgery, radiation, and chemotherapy by measuring HPV DNA and RNA in blood and cervical mucus. It aims to improve monitoring during treatment.
This study looks at whether certain markers in your blood (DNA from cancer cells and HPV) can help predict how well you do after first treatment for cervical cancer that has come back or spread. You would have extra blood draws during follow-up visits.
This trial is testing a new vaccine designed to help your immune system fight cervical cancer caused by HPV types 16 or 18. It is for women who are receiving standard treatment like surgery, chemotherapy, or radiation.
Hear when a new Locally Advanced Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.